Process design & scale-up / INTERACTIVE LESSON 37

Thirteen thousand kilograms in for one kilogram of peptide out

At the commercial and late-trial stage, the standard bead-based way to make a peptide averaged about 13,000 kilograms of inputs, water included, for each kilogram of peptide. The median for small-molecule drugs sits between 168 and 308 kilograms per kilogram.

CHANGE A CONDITION. SEE WHAT FOLLOWS.

Teaching model
Estimated inputs per kilogram of peptide for a 19 amino acid chain, against the late-stage average, the small-molecule median band and the oligonucleotide averageInputs per kilogram of peptide out, water included.010,00020,00030,00040,00050,000168 to 3084,299Late-stage average 13,06316,616Small moleculesmedian bandOligonucleotidesaverageYour estimate19 amino acids42 to 78×late-stage average, 13,063,against the small-moleculemedian band, 168 to 308Your estimate19 amino acids × 874.516,616kg in per kg of peptide out54 to 99× the bandrange 3,097 to 44,650

Enlarge for bigger labels, then swipe sideways →

Chain length19 amino acids
Estimated inputs for this chain (amino acids × 874.5)16,616 kg per kg of peptide
Envelope at 163 to 2,350 per amino acid3,097 to 44,650 kg per kg
Estimate against the small-molecule band54 to 99 times
Late-stage average (13,063) against the small-molecule band42 to 78 times
Oligonucleotide average4,299 kg per kg

At 19 amino acids the rule of thumb gives 16,616 kg of inputs, water included, for each kg of peptide, inside an envelope of 3,097 to 44,650. The late-stage average of 13,063 is 42 to 78 times the small-molecule median band of 168 to 308. This estimate is 54 to 99 times that band and 3.9 times the oligonucleotide average of 4,299. Nineteen amino acids is the average chain length in the late-stage set, and the rule gives more than that set's own 13,063 because an average of per-amino-acid values is not an average of totals.

What this model assumes

Teaching approximation. Process mass intensity (PMI) is the total mass of raw materials, reactants and solvents, with water counted, divided by the mass of product. The page estimates it as amino acids × 874.5 kg per kg, the average of the paper's per-amino-acid values for its 14 commercial and Phase 3 solid-phase processes, with a shaded envelope from 163 to 2,350 per amino acid. The reference line is the paper's average for those 14 processes, 13,063, which ran from about 1,684 to 34,585 for chains of 6 to 43 amino acids. The small-molecule band is the median range of 168 to 308, so the 42 to 78 multiple compares an average with a median range (13,063 ÷ 308 = 42.4; 13,063 ÷ 168 = 77.8). The oligonucleotide average of 4,299 comes from a separate study. The per-amino-acid values vary about fourteen-fold, and an average of per-amino-acid values is not an average of totals: at 19 amino acids, the average chain length in the set, the rule gives 16,616 against the paper's own 13,063. The model ignores energy, the manufacture of the protected amino acids, solvent recovery, and the shift between purification and synthesis by development phase. It does not describe peptides made in yeast. The picture uses a linear axis, so the small-molecule band is drawn about one pixel tall, and the envelope is cut off at the top of the axis when it runs higher.

THE IDEA TO TAKE WITH YOU

The standard bead-based way to make a peptide averaged about 13,000 kilograms of inputs, water included, for each kilogram of drug at the commercial and late-trial stage.

Process mass intensity, or PMI, is everything that goes into a process divided by what comes out: all the raw materials, reactants and solvents, with water counted, over the mass of product. A PMI of 13,000 means 13,000 kilograms in for each kilogram out. It measures inputs. It says nothing about energy, and nothing about how hazardous the inputs are.

In a 2024 paper, fourteen companies shared data on 40 real peptide processes. The 14 commercial and Phase 3 processes that build the chain on resin beads, called solid-phase synthesis, averaged 13,063 kilograms in per kilogram of peptide out. Individual processes ran from about 1,700 to about 34,600.

Ordinary small-molecule drugs have a median PMI between 168 and 308. Against that band, 13,063 is 42 to 78 times higher: 13,063 divided by 308 is 42.4, and divided by 168 is 77.8. That compares an average with a median range, so treat the multiple as a rough one.

About half of the inputs go in after the build, in long purification runs that separate the right chain from near copies of it, according to the paper's general figure. Much of the rest goes in during the build, because the beads are rinsed with a large excess of solvent after every step. The split shifts with the development phase.

The slider turns this into a rough rule. The paper's per-amino-acid values for the commercial and Phase 3 processes average 874.5 kilograms in per kilogram out for each amino acid in the chain, with single values from 163 to 2,350. A 19 amino acid chain, the average length in that set, is estimated at about 16,600, and a 43 amino acid chain at about 37,600. The 19 amino acid estimate sits above the paper's 13,063 average because an average of per-amino-acid values is not an average of totals.

For comparison, a separate study of oligonucleotide drugs found an average PMI of 4,299.

QUICK CHECK

A PMI of 13,000 means 13,000 kilograms went in for each kilogram of peptide that came out. Does that mean 13,000 kilograms of harmful material was thrown away?

FROM UNDERSTANDING TO BUILDING

Taking a real process
beyond the lab?

Jon and I are building RARE Labs toward an autonomous pilot plant builder using AI and robotics. Join the waitlist for updates, and tell us what you’re trying to scale.

Join the RARE Labs waitlist ↗

FOLLOW THE EVIDENCE

Go a little deeper.